Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by consultant99on Aug 18, 2023 1:24pm
319 Views
Post# 35595182

RE:RE:RE:RE:RE:share activity

RE:RE:RE:RE:RE:share activity
Apparently there is another PP underway (a friend told a friend who told me). The company appears to be having issues meeting their PP targets and this started last September. The reason it feels like groundhog day is they seem to be continually trying to raise money from a shrinking pool of investors willing to buy more shares.

It is also apparent that one or more of these well heeled investors either gets wind of or simply deduces that the company needs more money and starts selling to raise money to buy back in through the PP. While the company has a 4 month mandated hold on the issued shares it doesn't seem to stop the cycles repeating as the cycle lengths decrease. This is like the 4th raise in the last year?

What this  means to the stock price is we seem range locked between 0.22 and 0.30 per share. Each new raise adds to share dilution at low prices instead of a rising share price in anticipation of BTD and AA. 

My suggestion of using convertible debentures is really a potential option to consider to break away from the current PP cycle.What is clear to me and many others is PPs are becoming less efficient and more predictable to the detriment of the company and existing shareholders (not participating).

 
<< Previous
Bullboard Posts
Next >>